Taiwan FDA registration 7f13b1b912300cc253ea5621d5cea98b

"Medtronic" citrate whole blood coagulation control group

TW: "美敦力"檸檬酸鹽全血凝血對照組

Taiwan·Risk Class 2·MEDTRONIC PERFUSION SYSTEMS·Registered Mar 14, 2006 – Mar 14, 2016Cancelled

Registration details

Analysis ID: 7f13b1b912300cc253ea5621d5cea98b
Customs Code: DHA00601614407

Company information

Manufacturer: MEDTRONIC PERFUSION SYSTEMS
Manufacturer Country: United States
Authorized Representative: MEDTRONIC (TAIWAN) LTD.

Product details

Intended Use: With an automatic coagulation timer, the coagulation test endpoint of the coagulation reaction requiring recalcification is determined.
Product Type (Level 1): B Hematology, pathology, and genetics
Product Type (Level 2): B.5425 Versatile system for in vitro agglutination studies
Import Information: import

Dates and status

Registration Date: Mar 14, 2006
Expiry Date: Mar 14, 2016
Cancellation Date: Apr 25, 2018

Cancellation information

Status: Logged out
Reason: 自行鍵入

About this record

Access comprehensive regulatory information for "Medtronic" citrate whole blood coagulation control group in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 7f13b1b912300cc253ea5621d5cea98b and manufactured by MEDTRONIC PERFUSION SYSTEMS. The authorized representative in Taiwan is MEDTRONIC (TAIWAN) LTD..

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.